The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A natural language processing (NLP) approach for optical character recognition (OCR)-resilient extraction, correction, and structuring of karyotype data in oncology clinical notes.
 
Tian Kang
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Jessica Munger
Employment - Tempus AI, Inc
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Erik Mueller
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
Patents, Royalties, Other Intellectual Property - Patents assigned to IBM, Capital One, and Tempus AI..
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Arpita Saha
Employment - Cymabay Therapeutics (I); Tempus
Stock and Other Ownership Interests - Cymabay Therapeutics (I); Nurix (I); Summit Therapeutics (I); Tempus
Patents, Royalties, Other Intellectual Property - 18/679,338 GenAI - Agent Use Cases SYSTEMS AND METHODS FOR DEPLOYING A MACHINE-LEARNING MODEL FOR PERFORMING A SPECIFIC CLINICAL TASK; 63/712,334 Digital specialist - Patient Explorer SYSTEMS AND METHODS OF STRUCTURING AND QUERYING SUBJECT DATA; PCT/US24/31756 GenAI - PCT Omnibus SYSTEMS AND METHODS FOR GENERATING AND DEPLOYING TASK-SPECIFIC AGENTS
Travel, Accommodations, Expenses - Tempus
 
Victoria Chiou
Employment - AstraZeneca; Tempus AI, Inc.
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca; Tempus AI, Inc.
Travel, Accommodations, Expenses - AstraZeneca; Tempus AI, Inc.